E-7820

DB12505InvestigationalSmall molecule

E7820 has been investigated for the treatment of Colon Cancer and Rectal Cancer.

Chemical structure of E-7820
Formula / weight
C17H12N4O2S · 336.37 g/mol (avg)
Code names
E7820 · ER-68203-00

Resolves to

Compound
UNIITVH5K7949NCAS289483-69-8PubChem196970
Structure
InChIKeyLWGUASZLXHYWIV-UHFFFAOYSA-NSMILESCC1=C2C(=CNC2=C(NS(=O)(=O)C2=CC=CC(=C2)C#N)C=C1)C#N
Targets
P17301ITGA2

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with E-7820, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In